Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazinesSECCI, Daniela; BOLASCO, Adriana; CARRADORI, Simone et al.European journal of medicinal chemistry. 2012, Vol 58, pp 405-417, issn 0223-5234, 13 p.Article

Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivativesSECCI, Daniela; BIZZARRI, Bruna; BOLASCO, Adriana et al.European journal of medicinal chemistry. 2012, Vol 53, pp 246-253, issn 0223-5234, 8 p.Article